All Relations between Epilepsy and ds

Publication Sentence Publish Date Extraction Date Species
Yingchun Xu, Deng Chen, Ling Li. Optimal dose of fenfluramine in adjuvant treatment of drug-resistant epilepsy: evidence from randomized controlled trials. Frontiers in neurology. vol 15. 2024-04-09. PMID:38590719. several clinical trials have suggested that fenfluramine (ffa) is effective for the treatment of epilepsy in dravet syndrome (ds) and lennox-gastaut syndrome (lgs). 2024-04-09 2024-04-11 Not clear
Michael LoPresti, Ataru Igarashi, Yaoki Sonohara, Sally Bowditc. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan. Epilepsy & behavior : E&B. vol 154. 2024-03-31. PMID:38555725. lennox-gastaut syndrome (lgs), dravet syndrome (ds), and tuberous sclerosis complex (tsc)-associated epilepsy are rare conditions associated with severe childhood-onset epilepsy. 2024-03-31 2024-04-03 Not clear
Amber Postma, Crista A Minderhoud, Wim M Otte, Floor E Jansen, W B Gunning, Judith S Verhoeven, Marian J Jongmans, Janneke R Zinkstok, Eva H Brilstr. Understanding neurodevelopmental trajectories and behavioral profiles in SCN1A-related epilepsy syndromes. Epilepsy & behavior : E&B. vol 154. 2024-03-21. PMID:38513571. a pathogenic variant in scn1a can result in a spectrum of phenotypes, including dravet syndrome (ds) and genetic epilepsy with febrile seizures plus (gefs + ) syndrome. 2024-03-21 2024-03-24 Not clear
Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Yusuf Ismaila Ajayi, Olumide Akinmoju, Abiola Samuel Ayedun, Oluwapelumi Ikeoluwa Ayoola, Noah Oluwaseun Aderint. The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials. European journal of medical research. vol 29. issue 1. 2024-03-19. PMID:38500226. dravet syndrome (ds) is a rare and severe form of childhood epilepsy that is often refractory to conventional antiepileptic drugs. 2024-03-19 2024-03-21 Not clear
Declan Gallagher, Eduardo Pérez-Palma, Tobias Bruenger, Ismael Ghanty, Eva Brilstra, Berten Ceulemans, Nicole Chemaly, Iris de Lange, Christel Depienne, Renzo Guerrini, Davide Mei, Rikke S Møller, Rima Nabbout, Brigid M Regan, Amy L Schneider, Ingrid E Scheffer, An-Sofie Schoonjans, Joseph D Symonds, Sarah Weckhuysen, Sameer M Zuberi, Dennis Lal, Andreas Brunklau. Genotype-phenotype associations in 1018 individuals with SCN1A-related epilepsies. Epilepsia. 2024-02-27. PMID:38410936. scn1a variants are associated with epilepsy syndromes ranging from mild genetic epilepsy with febrile seizures plus (gefs+) to severe dravet syndrome (ds). 2024-02-27 2024-03-02 Not clear
Andrew Whitfield, Emma Leighton, Heather Boagey, Maria Ot. Dual diagnosis of epilepsy and dissociative seizures: Prescription patterns, feasibility and safety of rationalising antiseizure medication. Epilepsy & behavior : E&B. vol 152. 2024-01-26. PMID:38277845. patients with a dual-diagnosis of epilepsy and dissociative seizures (ds) have received far less attention than those with single pathology. 2024-01-26 2024-01-29 Not clear
Jingyi Tong, Tingting Ji, Ting Liu, Jiaqi Liu, Yibin Chen, Zongjun Li, Na Lu, Qifu L. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis. Epilepsy & behavior : E&B. vol 152. 2024-01-26. PMID:38277848. this study aimed to evaluate the efficacy and safety of six new antiseizure medications (asms) for adjunctive treatment in adult patients with focal epilepsy and adolescents with dravet syndrome (ds), lennox-gastaut syndrome (lgs), or tuberous sclerosis complex (tsc). 2024-01-26 2024-01-29 Not clear
Hueng-Chuen Fan, Ming-Tao Yang, Lung-Chang Lin, Kuo-Liang Chiang, Chuan-Mu Che. Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy. International journal of molecular sciences. vol 25. issue 1. 2024-01-11. PMID:38203200. dravet syndrome (ds), also known as severe myoclonic epilepsy of infancy, is a rare and drug-resistant form of developmental and epileptic encephalopathies, which is both debilitating and challenging to manage, typically arising during the first year of life, with seizures often triggered by fever, infections, or vaccinations. 2024-01-11 2024-01-13 Not clear
Clarissa Corniello, Fedele Dono, Giacomo Evangelista, Astrid Thomas, Marco Onofrj, Stefano L Sens. Diagnosis and treatment of status epilepticus in Down Syndrome (DS): A case report and systematic literature review. Seizure. vol 114. 2023-12-15. PMID:38101201. epilepsy is one of the most frequent neurological comorbidities in patients with down syndrome (ds). 2023-12-15 2023-12-18 Not clear
Nguyen Hong Nhu Y Trinh, Amy Susan Reid, Barbara Robertso. Perioperative considerations for adult patients with Dravet syndrome in regional centres. BMJ case reports. vol 16. issue 12. 2023-12-06. PMID:38056933. dravet syndrome (ds) is a rare and intractable severe form of epilepsy presenting in infancy with frequent prolonged myoclonic seizures and neurodevelopmental impairment, associated with a 2023-12-06 2023-12-10 Not clear
Carla Ballesteros-Sayas, Alicia Muñoz-Montero, Simona Giorgi, Elena Cardenal-Muñoz, Eulalia Turón-Viñas, Federico Pallardó, José Ángel Aiba. Non-pharmacological therapeutic needs in people with Dravet syndrome. Epilepsy & behavior : E&B. vol 150. 2023-11-30. PMID:38035538. ds is characterised by a drug-resistant epilepsy and by cognitive and behavioural disturbances. 2023-11-30 2023-12-10 Not clear
P Whyte-Fagundes, A Vance, A Carroll, F Figueroa, C Manukyan, S C Baraba. Testing of putative antiseizure drugs in a preclinical Dravet syndrome zebrafish model. bioRxiv : the preprint server for biology. 2023-11-28. PMID:38014342. dravet syndrome (ds) is a severe genetic epilepsy primarily caused by 2023-11-28 2023-11-29 zebrafish
Adam Strzelczyk, Lieven Lagae, Jo Wilmshurst, Andreas Brunklaus, Pasquale Striano, Felix Rosenow, Susanne Schubert-Bas. Dravet syndrome: a systematic literature review of the illness burden. Epilepsia open. 2023-09-26. PMID:37750463. we performed a systematic literature review and narrative synthesis according to a pre-registered protocol (prospero: crd42022376561) to identify the evidence associated with the burden of illness in dravet syndrome (ds), a developmental and epileptic encephalopathy characterised by drug-resistant epilepsy with neurocognitive and neurobehavioural impairment. 2023-09-26 2023-10-07 Not clear
Xiuli Wang, Huanbang Zhang, Yan Liu, Yang Xu, Bingyou Yang, Hua Li, Lixia Che. An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives. Bioorganic chemistry. vol 140. 2023-09-02. PMID:37659147. currently, epidiolex (cannabidiol) has been approved by the fda for the treatment of two rare and severe forms of epilepsy related diseases, namely lennox-gastaut syndrome (lgs) and dravet (ds). 2023-09-02 2023-09-07 Not clear
Mustafa Q Hameed, Benjamin Hui, Rui Lin, Paul C MacMullin, Andres Pascual-Leone, Sheryl Anne D Vermudez, Alexander Rotenber. Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome. Annals of clinical and translational neurology. 2023-07-14. PMID:37452008. dravet syndrome (ds) is a monogenic, often refractory, epilepsy resultant from scn1a haploinsufficiency in humans. 2023-07-14 2023-08-14 mouse
Xiaoping Du, Shizhong Lian, Meizhen Sun, Ruilong Li, Huifang Wang, Xiaoping Yang, Huifen Wang, Xiaobin Zhang, Fengpeng Wang, Yi Yao, Junhong Gu. Epileptic seizures worsen the gait and motor abnormalities in adult patients with Dravet syndrome(with a case report and Literature Review). Epilepsia open. 2023-07-07. PMID:37418349. dravet syndrome (ds), previously known as severe myoclonic epilepsy in infancy (smei), is considered the most serious "epileptic encephalopathy". 2023-07-07 2023-08-14 Not clear
Clarissa Corniello, Fedele Dono, Giacomo Evangelista, Stefano Consoli, Sibilla De Angelis, Sara Cipollone, Davide Liviello, Gaetano Polito, Sara Melchiorre, Mirella Russo, Alberto Granzotto, Francesca Anzellotti, Marco Onofrj, Astrid Thomas, Stefano L Sens. Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis. Seizure. vol 109. 2023-06-02. PMID:37267668. the late onset myoclonic epilepsy in down syndrome (lomeds) is a peculiar epilepsy type characterized by cortical myoclonus and generalized tonic-clonic seizures (gtcs), in people suffering from cognitive decline in down syndrome (ds). 2023-06-02 2023-08-14 Not clear
Casper Schmidt, Henning Laugese. Infra-low frequency neurofeedback training in Dravet syndrome: A case study. Epilepsy & behavior reports. vol 22. 2023-05-30. PMID:37252271. this case study examines how an intervention of infra-low frequency neurofeedback training (ilf-nft) affects the symptomatology of an eight-year-old patient with dravet syndrome (ds), a rare and highly disabling form of epilepsy. 2023-05-30 2023-08-14 Not clear
Simona Balestrini, Viola Doccini, Sabrina Giometto, Ersilia Lucenteforte, Salvatore De Masi, Elisa Giarola, Isabella Brambilla, Federica Pieroni, Marco Perulli, Domenica Battaglia, Nicola Specchio, Francesca Ragona, Tiziana Granata, Simona Pellacani, Annarita Ferrari, Carla Marini, Sara Matricardi, Elisabetta Cesaroni, Lucio Giordano, Patrizia Accorsi, Vittorio Sciruicchio, Paolo Tinuper, Tullio Messana, Angelo Russo, Dario Pruna, Margherita Nosadini, Valentina De Giorgis, Davide Caputo, Serena Pellegrin, Tommaso Lo Barco, Francesca Darra, Bernardo Dalla Bernardina, Renzo Guerrin. A registry for Dravet syndrome: the Italian experience. Epilepsia open. 2023-03-20. PMID:36938796. we describe the residras registry, dedicated to dravet syndrome (ds) and to other phenotypes related to scn1a mutations, as a paradigm of registry for rare and complex epilepsies. 2023-03-20 2023-08-14 Not clear
Pavel Klein, Gregory L Krauss, Bernhard J Steinhoff, Orrin Devinsky, Michael R Sperlin. Failure to use new breakthrough treatments for epilepsy. Epilepsia. 2023-03-01. PMID:36855241. in 2020 two new asms were launched in the us, cenobamate for focal epilepsy in adults and fenfluramine for dravet syndrome (ds). 2023-03-01 2023-08-14 Not clear